Today: 27 June 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Expedia stock drops on cautious 2026 margins — what to watch when EXPE trading resumes

Expedia stock drops on cautious 2026 margins — what to watch when EXPE trading resumes

Expedia shares fell 6.6% to $212.67 Friday after the company issued a softer full-year margin outlook despite raising its dividend and forecasting higher 2026 bookings and revenue. Fourth-quarter gross bookings rose 11% to $27 billion and revenue hit $3.55 billion. Several analysts cut price targets following the results. U.S. markets are closed Monday for Presidents Day.
14 February 2026
··
KLA stock in focus: KLAC heads into holiday week after $400 million India R&D pact

KLA stock in focus: KLAC heads into holiday week after $400 million India R&D pact

KLA Corp shares rose 0.92% to $1,464.13 Friday after announcing a deal with Tamil Nadu to build a major R&D campus in Chennai. The company plans to invest up to $400 million over 10 years, with the site expected to create up to 4,000 skilled jobs. The project will focus on AI-driven semiconductor technologies and process control tools, according to company and state officials.
14 February 2026
···
GE Aerospace stock price: repair robots, engine shortages and Airbus supply pressure in focus

GE Aerospace stock price: repair robots, engine shortages and Airbus supply pressure in focus

GE Aerospace shares rose 0.8% to $315.41 Friday as the company expanded automation and Lean methods to boost jet-engine repair output. GE has begun using robots for precision repairs at its Singapore hub to clear backlogs. Safran, GE’s CFM partner, forecast higher 2026 profits on civil engine demand. Airbus continues to press CFM for increased LEAP engine deliveries amid ongoing supply chain strains.
14 February 2026
···
Vertex stock jumps nearly 6% on Oppenheimer upgrade as traders size up new drug pipeline

Vertex stock jumps nearly 6% on Oppenheimer upgrade as traders size up new drug pipeline

Vertex shares jumped 5.7% to $491.47 Friday after Oppenheimer upgraded the stock, citing growth plans beyond cystic fibrosis. The company set 2026 revenue guidance at up to $13.1 billion, with at least $500 million expected from new products. Vertex highlighted gene-editing, pain, and kidney therapies in its outlook. U.S. markets close Monday for Presidents Day.
14 February 2026
··
Snowflake stock (SNOW) jumps 5% into long weekend as AI nerves and earnings near

Snowflake stock (SNOW) jumps 5% into long weekend as AI nerves and earnings near

Snowflake shares jumped 5.4% to $182.29 Friday after a previous drop, with trading volume at 8.33 million shares. The move followed lower Treasury yields and U.S. inflation data that fueled bets on Fed rate cuts. Snowflake recently announced a $200 million OpenAI partnership and a deal with U.S. Figure Skating. The company reports earnings after market close on Feb. 25.
14 February 2026
····
Morgan Stanley stock rebounds after Thursday slide as CPI cools; Fed minutes, Basel rules loom

Morgan Stanley stock rebounds after Thursday slide as CPI cools; Fed minutes, Basel rules loom

Morgan Stanley shares closed up 1.8% at $171.15 Friday, rebounding after a 4.9% drop Thursday. U.S. inflation data came in cooler than expected, easing rate concerns and lifting stocks. Investors remain cautious ahead of Fed minutes Feb. 18 and possible new big-bank capital rules. Morgan Stanley declared dividends on several preferred stock series.
14 February 2026
···
1 … 228 229 230 231 232 … 875

Stock Market Today

  • 4DMedical (ASX:4DX) Gains Investor Attention Ahead of Life Sciences Forum
    June 27, 2026, 4:52 PM EDT. 4DMedical (ASX:4DX) has seen a resurgence in investor interest ahead of its June 24 presentation at the Life Sciences Virtual Investor Forum. CEO Andreas Fouras will discuss the company's respiratory imaging technology and strategic positioning in the US and Australia. Despite recent short-term volatility with shares down 9% on the day and 8% over the week, the stock has surged 25% over the past month. The company's innovative non-invasive, contrast-free lung scanning CT:VQ technology underpins optimistic long-term momentum, though shares trade about 19% below the A$4.97 analyst price target. Market sentiment remains divided, with a significant undervaluation narrative suggesting a fair value of A$11.11, contingent on rapid adoption and high margins. Investors face balancing growth expectations against risks including slower uptake and pricing pressures.

Latest articles

IHG buyback near record highs puts capital-return math in focus

IHG buyback near record highs puts capital-return math in focus

27 June 2026
IHG bought back 200,000 shares for $34 million at near-record prices through June 25, shrinking its share count as its London stock closed Friday at $171.55, just 2.4% below its all-time high; this aggressive buyback, part of a new $950 million program, means future per-share growth will rely more on room and fee expansion, with investors eyeing upcoming half-year results on August 11.
NextEra Energy (NYSE:NEE) lags utilities as tax-credit deadline nears

NextEra Energy (NYSE:NEE) lags utilities as tax-credit deadline nears

27 June 2026
NextEra Energy (NEE) closed up 0.98% at $88.56 on Friday with volume 144% of its 65-day average, but underperformed the Utilities Select Sector SPDR Fund (XLU) despite being its largest holding, as investors weighed deal and project risks ahead of a July 4 clean-energy tax-credit deadline that could impact project economics.
Go toTop